Constitutive NF-κB activity, often driven by chronic inflammation or oncogenic mutations, supports tumor cell proliferation, inhibits apoptosis, promotes angiogenesis, and facilitates epithelial–mesenchymal transition (EMT), thereby fostering metastasis [47,48]. The gene discussed is NFKB1; the disease is neoplasm.